Eupraxia Pharmaceuticals(EPRX)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EPRX Eupraxia Pharmaceuticals

盘后交易 07-11 18:57:50 EDT

5.36

-0.26

-4.60%

盘后5.52

+0.16+2.99%

17:47 EDT

最高5.54	最低5.36	成交量5,842
今开5.52	昨收5.62	日振幅3.20%
总市值1.92亿	流通市值1.33亿	总股本3,585万
成交额3.21万	换手率0.02%	流通股本2,488万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"EPRX","market":"US","secType":"STK","nameCN":"Eupraxia Pharmaceuticals","latestPrice":5.36,"timestamp":1752264000000,"preClose":5.6186,"halted":0,"volume":5842,"hourTrading":{"tag":"盘后","latestPrice":5.52,"preClose":5.36,"latestTime":"17:47 EDT","volume":51,"amount":281.439981,"timestamp":1752270431870},"delay":0,"floatShares":24882415,"shares":35849353,"eps":-0.764907,"marketStatus":"盘后交易","change":-0.2586,"latestTime":"07-11 18:57:50 EDT","open":5.52,"high":5.54,"low":5.36,"amount":32070.6679134,"amplitude":0.032036,"askPrice":5.52,"askSize":20,"bidPrice":3,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.764907,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1752278400000},"marketStatusCode":4,"adr":0,"listingDate":1712289600000,"exchange":"NASDAQ","adjPreClose":5.6186,"postHourTrading":{"tag":"盘后","latestPrice":5.52,"preClose":5.36,"latestTime":"17:47 EDT","volume":51,"amount":281.439981,"timestamp":1752270431870},"volumeRatio":0.715949},"requestUrl":"/m/hq/s/EPRX","defaultTab":"news","newsList":[{"id":"2511457613","title":"Eupraxia Pharmaceuticals Inc.盘中异动 股价大涨7.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511457613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511457613?lang=zh_cn&edition=full","pubTime":"2025-02-15 01:33","pubTimestamp":1739554383,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日01时33分，Eupraxia Pharmaceuticals Inc.股票出现异动，股价快速上涨7.10%。Eupraxia Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.60%。其相关个股中，Moleculin Biotech, Inc.、Allogene Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2888.41%、758.41%、592.79%，振幅较大的相关个股有Moleculin Biotech, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为71.65%、70.63%、66.45%。Eupraxia Pharmaceuticals Inc.公司简介：Eupraxia Pharmaceuticals Inc 是一家临床阶段生物技术公司，致力于开发局部给药的现有药物缓释替代品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215013303abcf2d63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215013303abcf2d63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EPRX"],"gpt_icon":0},{"id":"2506308078","title":"Eupraxia Pharmaceuticals Inc.盘中异动 大幅上涨7.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506308078","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506308078?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:35","pubTimestamp":1737988545,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时35分，Eupraxia Pharmaceuticals Inc.股票出现异动，股价快速上涨7.51%。Eupraxia Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Akero Therapeutics, Inc.、89Bio, Inc.、Onconetix, Inc.涨幅较大，Onconetix, Inc.、Pmgc Holdings Inc.、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为734.08%、46.86%、41.37%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Immatics N V C/Wts 01/07/2025 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为65.16%、53.75%、34.60%。Eupraxia Pharmaceuticals Inc.公司简介：Eupraxia Pharmaceuticals Inc 是一家临床阶段生物技术公司，致力于开发局部给药的现有药物缓释替代品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223545a2316bf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223545a2316bf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EPRX","BK4139"],"gpt_icon":0},{"id":"2504819114","title":"Eupraxia Pharmaceuticals Inc.盘中异动 股价大涨6.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504819114","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504819114?lang=zh_cn&edition=full","pubTime":"2025-01-18 04:57","pubTimestamp":1737147421,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日04时57分，Eupraxia Pharmaceuticals Inc.股票出现波动，股价急速拉升6.31%。Eupraxia Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.64%。其相关个股中，Channel Therapeutics Corporation、Immatics N V C/Wts 01/07/2025 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Aditxt, Inc.、Channel Therapeutics Corporation、Scorpius Holdings, Inc.较为活跃，换手率分别为252.87%、224.16%、119.58%，振幅较大的相关个股有Channel Therapeutics Corporation、Immatics N V C/Wts 01/07/2025 、Scorpius Holdings, Inc.，振幅分别为150.00%、117.68%、68.41%。Eupraxia Pharmaceuticals Inc.公司简介：Eupraxia Pharmaceuticals Inc 是一家临床阶段生物技术公司，致力于开发局部给药的现有药物缓释替代品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118045701abaf027c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118045701abaf027c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EPRX"],"gpt_icon":0},{"id":"2500970581","title":"Eupraxia Pharmaceuticals Inc.盘中异动 股价大跌6.94%报2.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500970581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500970581?lang=zh_cn&edition=full","pubTime":"2025-01-03 01:48","pubTimestamp":1735840116,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日01时48分，Eupraxia Pharmaceuticals Inc.股票出现异动，股价快速跳水6.94%。截至发稿，该股报2.95美元/股，成交量1236股，换手率0.00%，振幅3.79%。Eupraxia Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Eupraxia Pharmaceuticals Inc.公司简介：Eupraxia Pharmaceuticals Inc 是一家临床阶段生物技术公司，致力于开发局部给药的现有药物缓释替代品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010301483698592605&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010301483698592605&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EPRX"],"gpt_icon":0},{"id":"2492644429","title":"Eupraxia Pharmaceuticals Inc.盘中异动 早盘股价大跌6.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492644429","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492644429?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:31","pubTimestamp":1734705075,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日22时31分，Eupraxia Pharmaceuticals Inc.股票出现异动，股价大幅跳水6.33%。截至发稿，该股报2.81美元/股，成交量300股，换手率0.00%，振幅0.00%。Eupraxia Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Eupraxia Pharmaceuticals Inc.公司简介：Eupraxia Pharmaceuticals Inc 是一家临床阶段生物技术公司，致力于开发局部给药的现有药物缓释替代品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223115984cfbf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223115984cfbf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EPRX"],"gpt_icon":0},{"id":"2490382692","title":"Eupraxia Pharmaceuticals Inc.盘中异动 早盘股价大跌5.51%报3.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490382692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490382692?lang=zh_cn&edition=full","pubTime":"2024-12-12 22:31","pubTimestamp":1734013911,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日22时31分，Eupraxia Pharmaceuticals Inc.股票出现异动，股价大幅下挫5.51%。Eupraxia Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.10%。其相关个股中，Palisade Bio, Inc.、Trevi Therapeutics, Inc.、Aptevo Therapeutics Inc.涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为1897.77%、439.44%、50.37%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Palisade Bio, Inc.、Entero Therapeutics Inc.，振幅分别为17.38%、15.00%、11.46%。Eupraxia Pharmaceuticals Inc.公司简介：Eupraxia Pharmaceuticals Inc 是一家临床阶段生物技术公司，致力于开发局部给药的现有药物缓释替代品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212223151ab72a853&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212223151ab72a853&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EPRX","BK4139"],"gpt_icon":0},{"id":"2489116709","title":"Eupraxia Pharmaceuticals Inc.盘中异动 早盘股价大跌5.54%报3.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489116709","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489116709?lang=zh_cn&edition=full","pubTime":"2024-12-05 00:12","pubTimestamp":1733328744,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日00时12分，Eupraxia Pharmaceuticals Inc.股票出现异动，股价大幅下跌5.54%。截至发稿，该股报3.07美元/股，成交量3346股，换手率0.01%，振幅6.46%。Eupraxia Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Eupraxia Pharmaceuticals Inc.公司简介：Eupraxia Pharmaceuticals Inc 是一家临床阶段生物技术公司，致力于开发局部给药的现有药物缓释替代品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120500122498e561d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120500122498e561d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EPRX"],"gpt_icon":0},{"id":"2488745941","title":"Eupraxia Pharmaceuticals Inc.盘中异动 急速跳水7.06%报3.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488745941","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488745941?lang=zh_cn&edition=full","pubTime":"2024-12-03 23:19","pubTimestamp":1733239148,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日23时19分，Eupraxia Pharmaceuticals Inc.股票出现异动，股价快速跳水7.06%。截至发稿，该股报3.16美元/股，成交量1021股，换手率0.00%，振幅0.00%。Eupraxia Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Eupraxia Pharmaceuticals Inc.公司简介：Eupraxia Pharmaceuticals Inc 是一家临床阶段生物技术公司，致力于开发局部给药的现有药物缓释替代品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203231909971b6061&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203231909971b6061&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EPRX"],"gpt_icon":0},{"id":"2486387573","title":"Eupraxia Pharmaceuticals Inc.股价飙升10.07% 市值涨443.79万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486387573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486387573?lang=zh_cn&edition=full","pubTime":"2024-11-27 23:38","pubTimestamp":1732721881,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日23时38分，Eupraxia Pharmaceuticals Inc.股票出现异动，股价大幅上涨10.07%。截至发稿，该股报3.36美元/股，成交量407股，换手率0.00%，振幅3.61%。Eupraxia Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Eupraxia Pharmaceuticals Inc.公司简介：Eupraxia Pharmaceuticals Inc 是一家临床阶段生物技术公司，致力于开发局部给药的现有药物缓释替代品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127233801abe38977&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127233801abe38977&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EPRX","BK4139"],"gpt_icon":0},{"id":"2484117229","title":"Eupraxia Pharmaceuticals Inc.盘中异动 早盘股价大涨7.36%报3.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484117229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484117229?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:30","pubTimestamp":1732113042,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时30分，Eupraxia Pharmaceuticals Inc.股票出现异动，股价快速上涨7.36%。截至发稿，该股报3.50美元/股，成交量7008股，换手率0.02%，振幅0.00%。Eupraxia Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Eupraxia Pharmaceuticals Inc.公司简介：Eupraxia Pharmaceuticals Inc 是一家临床阶段生物技术公司，致力于开发局部给药的现有药物缓释替代品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223043abd231a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223043abd231a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EPRX","BK4139"],"gpt_icon":0},{"id":"2483308804","title":"Eupraxia Pharmaceuticals Inc.盘中异动 股价大涨6.34%报3.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483308804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483308804?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:31","pubTimestamp":1731594663,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时31分，Eupraxia Pharmaceuticals Inc.股票出现异动，股价快速上涨6.34%。截至发稿，该股报3.02美元/股，成交量195股，换手率0.00%，振幅0.00%。Eupraxia Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.42%。Eupraxia Pharmaceuticals Inc.公司简介：Eupraxia Pharmaceuticals Inc 是一家临床阶段生物技术公司，致力于开发局部给药的现有药物缓释替代品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422310395be2c2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422310395be2c2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EPRX","BK4139"],"gpt_icon":0},{"id":"2482738526","title":"Eupraxia Pharmaceuticals Inc.盘中异动 快速跳水5.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738526?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:31","pubTimestamp":1731335512,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时31分，Eupraxia Pharmaceuticals Inc.股票出现异动，股价大幅跳水5.99%。Eupraxia Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Cero Therapeutics Holdings, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Revelation Biosciences, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为406.68%、125.25%、61.02%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Oragenics Inc.、Aptevo Therapeutics Inc.，振幅分别为22.57%、9.87%、7.01%。Eupraxia Pharmaceuticals Inc.公司简介：Eupraxia Pharmaceuticals Inc 是一家临床阶段生物技术公司，致力于开发局部给药的现有药物缓释替代品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223153971a5ade&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223153971a5ade&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EPRX"],"gpt_icon":0},{"id":"2481313101","title":"Eupraxia Pharmaceuticals Inc.盘中异动 急速上涨5.19%报3.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481313101","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481313101?lang=zh_cn&edition=full","pubTime":"2024-11-08 01:49","pubTimestamp":1731001774,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日01时49分，Eupraxia Pharmaceuticals Inc.股票出现波动，股价快速上涨5.19%。截至发稿，该股报3.27美元/股，成交量5904股，换手率0.02%，振幅0.97%。Eupraxia Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.91%。Eupraxia Pharmaceuticals Inc.公司简介：Eupraxia Pharmaceuticals Inc 是一家临床阶段生物技术公司，致力于开发局部给药的现有药物缓释替代品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108014934abaad778&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108014934abaad778&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EPRX"],"gpt_icon":0},{"id":"2481554595","title":"Eupraxia Pharmaceuticals Inc.盘中异动 股价大涨8.39%报3.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481554595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481554595?lang=zh_cn&edition=full","pubTime":"2024-11-05 04:47","pubTimestamp":1730753241,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日04时47分，Eupraxia Pharmaceuticals Inc.股票出现异动，股价急速拉升8.39%。截至发稿，该股报3.36美元/股，成交量3.7876万股，换手率0.11%，振幅9.61%。Eupraxia Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.40%。Eupraxia Pharmaceuticals Inc.公司简介：Eupraxia Pharmaceuticals Inc 是一家临床阶段生物技术公司，致力于开发局部给药的现有药物缓释替代品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105044721971a43e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105044721971a43e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EPRX","BK4139"],"gpt_icon":0},{"id":"2480881741","title":"Eupraxia Pharmaceuticals Inc.盘中异动 快速拉升6.40%报2.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480881741","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480881741?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:43","pubTimestamp":1730468597,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时43分，Eupraxia Pharmaceuticals Inc.股票出现异动，股价急速上涨6.40%。截至发稿，该股报2.66美元/股，成交量1448股，换手率0.00%，振幅0.00%。Eupraxia Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为1.00%。Eupraxia Pharmaceuticals Inc.公司简介：Eupraxia Pharmaceuticals Inc 是一家临床阶段生物技术公司，致力于开发局部给药的现有药物缓释替代品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101214317971a3d9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101214317971a3d9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EPRX"],"gpt_icon":0},{"id":"2479755288","title":"Eupraxia Pharmaceuticals Inc.盘中异动 早盘股价大涨9.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479755288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479755288?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:30","pubTimestamp":1730208638,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时30分，Eupraxia Pharmaceuticals Inc.股票出现波动，股价大幅上涨9.80%。Eupraxia Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Glycomimetics, Inc.、Lixte Biotechnology Holdings, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Lixte Biotechnology Holdings, Inc.、Novabay Pharmaceuticals, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为501.73%、246.38%、119.61%，振幅较大的相关个股有Hepion Pharmaceuticals, Inc.、Clearmind Medicine Inc.、Viracta Therapeutics, Inc.，振幅分别为3.53%、3.52%、3.44%。Eupraxia Pharmaceuticals Inc.公司简介：Eupraxia Pharmaceuticals Inc 是一家临床阶段生物技术公司，致力于开发局部给药的现有药物缓释替代品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921303898e3f168&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921303898e3f168&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EPRX","BK4139"],"gpt_icon":0},{"id":"2477893764","title":"Eupraxia Pharmaceuticals Inc.盘中异动 快速下挫5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477893764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477893764?lang=zh_cn&edition=full","pubTime":"2024-10-22 00:13","pubTimestamp":1729527195,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日00时13分，Eupraxia Pharmaceuticals Inc.股票出现异动，股价快速跳水5.58%。Eupraxia Pharmaceuticals Inc.股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Genprex, Inc.、Gri Bio, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为7039.77%、3280.68%、1426.48%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为369.73%、157.02%、148.15%。Eupraxia Pharmaceuticals Inc.公司简介：Eupraxia Pharmaceuticals Inc 是一家临床阶段生物技术公司，致力于开发局部给药的现有药物缓释替代品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102200131698e3d94c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102200131698e3d94c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EPRX"],"gpt_icon":0},{"id":"2476127962","title":"Eupraxia Pharmaceuticals Inc.盘中异动 股价大涨6.05%报2.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476127962","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476127962?lang=zh_cn&edition=full","pubTime":"2024-10-17 21:31","pubTimestamp":1729171868,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日21时31分，Eupraxia Pharmaceuticals Inc.股票出现波动，股价大幅上涨6.05%。截至发稿，该股报2.63美元/股，成交量157股，换手率0.00%，振幅0.00%。Eupraxia Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Eupraxia Pharmaceuticals Inc.公司简介：Eupraxia Pharmaceuticals Inc 是一家临床阶段生物技术公司，致力于开发局部给药的现有药物缓释替代品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410172131089f4a85cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410172131089f4a85cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EPRX","BK4139"],"gpt_icon":0},{"id":"2475997865","title":"Eupraxia Pharmaceuticals Inc.股价上涨13.58% 市值跌406.5万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475997865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475997865?lang=zh_cn&edition=full","pubTime":"2024-10-16 21:30","pubTimestamp":1729085427,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日21时30分，Eupraxia Pharmaceuticals Inc.股票出现波动，股价急速拉升13.58%。截至发稿，该股报2.76美元/股，成交量3174股，换手率0.01%，振幅0.00%。Eupraxia Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Eupraxia Pharmaceuticals Inc.公司简介：Eupraxia Pharmaceuticals Inc 是一家临床阶段生物技术公司，致力于开发局部给药的现有药物缓释替代品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016213027a1e11e84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016213027a1e11e84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EPRX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.eupraxiapharma.com","stockEarnings":[{"period":"1week","weight":0.0424},{"period":"1month","weight":0.4117},{"period":"3month","weight":0.8574},{"period":"6month","weight":0.8729},{"period":"1year","weight":1.0138},{"period":"ytd","weight":0.7724}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":0.0377},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0781},{"period":"1year","weight":0.1149},{"period":"ytd","weight":0.0678}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Eupraxia Pharmaceuticals Inc.于2011年5月在不列颠哥伦比亚省注册成立。Eupraxia是一家临床阶段的生物技术公司，专注于开发现有药物的本地交付、缓释替代品，以创造“首次”用于分子或药物类别的新产品，或用于已经确定疗效的适应症的“同类最佳”产品。利用其专有和创新的DiffusiphereTM递送技术，Eupraxia的目标是在正确的地点、正确的时间内为有高度未满足医疗需求的适应症提供正确剂量的药物。优普拉夏的每一种候选产品都旨在通过提供比目前可用的治疗更持久的活性，结合改进的药代动力学（“PK”）和相关安全性，并结合精确靶向的局部给药，从而提高患者的获益。","exchange":"NASDAQ","name":"Eupraxia Pharmaceuticals","nameEN":"Eupraxia Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Eupraxia Pharmaceuticals(EPRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Eupraxia Pharmaceuticals(EPRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Eupraxia Pharmaceuticals,EPRX,Eupraxia Pharmaceuticals股票,Eupraxia Pharmaceuticals股票老虎,Eupraxia Pharmaceuticals股票老虎国际,Eupraxia Pharmaceuticals行情,Eupraxia Pharmaceuticals股票行情,Eupraxia Pharmaceuticals股价,Eupraxia Pharmaceuticals股市,Eupraxia Pharmaceuticals股票价格,Eupraxia Pharmaceuticals股票交易,Eupraxia Pharmaceuticals股票购买,Eupraxia Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Eupraxia Pharmaceuticals(EPRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Eupraxia Pharmaceuticals(EPRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况